<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="tIII-ijmm-46-02-0489" orientation="portrait" position="float">
 <label>Table III</label>
 <caption>
  <p>Natural compounds with antiviral actions.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th valign="top" align="left" rowspan="1" colspan="1">Substance analyzed (Ref.)</th>
    <th valign="top" align="left" rowspan="1" colspan="1">Viral molecule inhibited; mechanism</th>
    <th valign="top" align="left" rowspan="1" colspan="1">Method and/or software used for testing</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Anisotine and vasicoline of 
     <italic>Justicia adhatoda</italic> (
     <xref rid="b65-ijmm-46-02-0489" ref-type="bibr">65</xref>)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Protease; RNA Replicase inhibitor</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Using COVID-19 Docking Server</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Phycocyanobilin, Riboflavin, Cyanidin, Daidzein, Genistein (
     <xref rid="b69-ijmm-46-02-0489" ref-type="bibr">69</xref>)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Protease (Mpro); RNA Replicase inhibitors</td>
    <td valign="top" align="left" rowspan="1" colspan="1">COVID-19 Docking Server to inhibit Mpro and RdRp</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Curcumin (
     <xref rid="b70-ijmm-46-02-0489" ref-type="bibr">70</xref>)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Protease inhibitor</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Structure of metabolite and COVID_19 protease from PubChem and Protein Data Bank (PDB); molecular docking by MVD (Molegro Virtual Docker)</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">For 6LU7: Nigellidine -6.29 Kcal/mol; chloroquine -6.29; OH-chloroquine -5.57; favipiravir -4.23; For 2GTB: Î±-Hederin -6.50 kcal/mol; chloroquine -6.20; OH-chloroquine -5.51; favipiravir -4.12 (
     <xref rid="b68-ijmm-46-02-0489" ref-type="bibr">68</xref>)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Proteases (3CLpro andMpro) 6LU7 and 2GTB inhibitors</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Docking of compounds from 
     <italic>Nigella sativa</italic> and drugs performed with Molecular Operating Environment software (MOE)
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
